Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Sheep And Goat Pox Vaccines Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The sheep and goat pox vaccines market size has experienced consistent expansion in recent years. It is projected to increase from $60.43 billion in 2025 to $63.19 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 4.6%. This historical growth can be ascribed to factors such as frequent outbreaks of sheep and goat pox, the limited availability of early vaccine options, government-led vaccination campaigns, the growing livestock population in developing regions, and the adoption of traditional live attenuated vaccines.
The market size for sheep and goat pox vaccines is anticipated to experience consistent expansion over the upcoming years. It will grow to $73.74 billion in 2030 at a compound annual growth rate (CAGR) of 3.9%. Factors contributing to this anticipated growth include improvements in recombinant and DNA-based vaccine technologies, a rising need for adjuvanted inactivated vaccines, the expansion of preventive veterinary care initiatives, increased investments in livestock farming, and a heightened understanding of biosecurity protocols in animal husbandry. Key trends expected during the forecast period involve the creation of multivalent vaccines to offer wider protection, a growing preference for injectable vaccines in livestock, a greater emphasis on recombinant and DNA-based vaccines, increasing knowledge regarding the prevention of sheep and goat diseases, and the broadening of veterinary vaccination programs into rural areas.
Get A Free Sample Report With In-Depth Market Insights:
Sheep And Goat Pox Vaccines Market Expansion Drivers: What’s Shaping Future Growth?
The increasing need for livestock items is set to drive the expansion of the sheep and goat pox vaccines market in the future. Livestock products encompass various goods and materials obtained from domesticated animals reared in agricultural environments. This rising demand for such products is influenced by multiple factors, including income and population growth, urbanization, health considerations, evolving consumer preferences, globalization, and economic advancement. Sheep and goat pox vaccines play a crucial role in protecting livestock products by averting disease outbreaks and maintaining the health and productivity of sheep and goat populations. For example, in February 2024, the UK-based Department for Environment, Food, and Rural Affairs reported a rise in red meat production, with mutton and lamb production showing the largest increase at 2.9%. Consequently, the growing demand for livestock products is anticipated to propel the growth of the sheep and goat pox vaccines market. The expanding financial commitment to veterinary research and development (R&D) is projected to advance the sheep and goat pox vaccines market moving forward. This investment involves funds from governments, private entities, and organizations dedicated to investigating, innovating, and creating novel solutions for enhancing animal health. This includes the development of vaccines, treatments, diagnostic tools, and disease prevention strategies. The rise in veterinary R&D is driven by a growing acknowledgment of the necessity to innovate and improve animal health solutions, particularly in response to emerging and re-emerging livestock diseases. Increased investment directly facilitates the development of more effective and safer vaccines for animal illnesses. For instance, in May 2024, the U.S.-based government agency Animal and Plant Health Inspection Service (APHIS) stated that the USDA awarded over $22.2 million to 81 new projects. These projects, led by 48 states, universities, industry organizations, and veterinary diagnostic laboratories, aim to strengthen prevention, preparedness, early detection, and rapid response to the most detrimental diseases threatening U.S. livestock. Hence, the increasing investment in veterinary research and development (R&D) is fueling the growth of the sheep and goat pox vaccines market.
Sheep And Goat Pox Vaccines Market Segment Breakdown: Which Categories Lead On Revenue?
The sheep and goat pox vaccines market covered in this report is segmented –
1) By Type: Live Attenuated Vaccines, Inactivated Vaccines, Other Types
2) By Route Of Administration: Injectable, Intranasal
3) By Application: Sheep, Goat
Subsegments:
1) By Live Attenuated Vaccines: Monovalent Live Attenuated Vaccines, Multivalent Live Attenuated Vaccines
2) By Inactivated Vaccines: Adjuvanted Inactivated Vaccines, Non-Adjuvanted Inactivated Vaccines
3) By Other Types: Recombinant Vaccines, DNA-Based Vaccines
Sheep And Goat Pox Vaccines Market Strategic Trends: What Defines The Next Growth Phase?
Major companies operating in the sheep and goat pox vaccines market are increasingly forming strategic alliances to create innovative vaccines. These partnerships benefit the sheep and goat pox vaccines market by pooling resources and expertise, propelling research and development, expanding market access, and accelerating commercialization. For example, in February 2024, Hester Biosciences, an India-based biotechnology and vaccine company, introduced a combined PPR-Goatpox vaccine, which offers protection against both Peste des Petits Ruminants (PPR) and Goatpox in a single dose. This integrated vaccine simplifies immunization schedules, lessens handling stress, reduces costs associated with vaccination, and enhances overall flock health. This advancement originated from a strategic technology transfer from the Indian Council of Agricultural Research–Indian Veterinary Research Institute (ICAR-IVRI), which enabled Hester to commercialize the indigenous vaccine by utilizing IVRI’s research expertise alongside Hester’s manufacturing and distribution capabilities, thus improving preventive livestock healthcare and vaccine availability in regions where these diseases are prevalent.
Sheep And Goat Pox Vaccines Market Industry Leaders And Competitive Landscape
Major companies operating in the sheep and goat pox vaccines market are Indian Immunologicals Ltd., Kemin Industries, Bimeda Biologicals, Hester Biosciences Limited, Dollvet, MSD Animal Health, MCI Santé Animale, Creative Biolabs, Biovex Inc., Advacare Pharma, Brilliant Bio Pharma Private Limited, Intervac (PVT) Ltd., Agrinnovate India Limited, Bio-Med Pvt Limited, JOVAC, Vetal Animal Health Products, Kenya Veterinary Vaccines Production Institute, Vedall Pharma Private Limited, Farmer’s Pharma Private Limited, Institute of Veterinary Biological Products
View The Full Sheep And Goat Pox Vaccines Market Report:
Sheep And Goat Pox Vaccines Market Regional Analysis And Top Geography
North America was the largest region in the sheep and goat pox vaccines market in 2025. The regions covered in the sheep and goat pox vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
